IFNG and cancer: Our results provide the first-hand data supporting the benefits of using IFNγ, and especially when combined with CAP, for colorectal cancer treatment that not only opens a novel avenue for the clinical use of IFNγ but also broadens our understandings on the anti-cancer mechanism of CAP for clinical translation.